Muscarinic-agonist and guanine nucleotide activation of polyphosphoinositide phosphodiesterase in isolated islet-cell membranes.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 1147480)

Published in Biochem J on December 15, 1986

Authors

M E Dunlop, R G Larkins

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81

Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain. J Biol Chem (1984) 6.58

The polyphosphoinositide phosphodiesterase of erythrocyte membranes. Biochem J (1981) 6.16

The stimulation of inositol lipid metabolism that accompanies calcium mobilization in stimulated cells: defined characteristics and unanswered questions. Philos Trans R Soc Lond B Biol Sci (1981) 5.30

Role of guanine nucleotide binding protein in the activation of polyphosphoinositide phosphodiesterase. Nature (1985) 5.10

Purification and properties of the inhibitory guanine nucleotide regulatory unit of brain adenylate cyclase. J Biol Chem (1984) 3.82

The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. V. An obligatory role of guanylnucleotides in glucagon action. J Biol Chem (1971) 3.52

Involvement of guanine nucleotide-binding protein in the gating of Ca2+ by receptors. Nature (1983) 3.21

Simultaneous inhibitions of inositol phospholipid breakdown, arachidonic acid release, and histamine secretion in mast cells by islet-activating protein, pertussis toxin. A possible involvement of the toxin-specific substrate in the Ca2+-mobilizing receptor-mediated biosignaling system. J Biol Chem (1985) 3.18

Identification of the predominant substrate for ADP-ribosylation by islet activating protein. J Biol Chem (1983) 3.11

Purification of the regulatory component of adenylate cyclase. Proc Natl Acad Sci U S A (1980) 2.81

ADP-ribosylation of the specific membrane protein by islet-activating protein, pertussis toxin, associated with inhibition of a chemotactic peptide-induced arachidonate release in neutrophils. A possible role of the toxin substrate in Ca2+-mobilizing biosignaling. J Biol Chem (1984) 2.62

5-Hydroxytryptamine stimulates inositol phosphate production in a cell-free system from blowfly salivary glands. Evidence for a role of GTP in coupling receptor activation to phosphoinositide breakdown. J Biol Chem (1985) 2.60

The regulatory components of adenylate cyclase and transducin. A family of structurally homologous guanine nucleotide-binding proteins. J Biol Chem (1983) 2.12

Pertussis toxin inhibits fMet-Leu-Phe- but not phorbol ester-stimulated changes in rabbit neutrophils: role of G proteins in excitation response coupling. Proc Natl Acad Sci U S A (1985) 2.05

Chemoattractant receptor-induced hydrolysis of phosphatidylinositol 4,5-bisphosphate in human polymorphonuclear leukocyte membranes. Requirement for a guanine nucleotide regulatory protein. J Biol Chem (1985) 2.03

Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via alpha-adrenergic, cholinergic, and opiate receptors in neuroblastoma x glioma hybrid cells. J Biol Chem (1983) 1.98

Modification by islet-activating protein of receptor-mediated regulation of cyclic AMP accumulation in isolated rat heart cells. J Biol Chem (1981) 1.89

Pertussis toxin does not inhibit muscarinic-receptor-mediated phosphoinositide hydrolysis or calcium mobilization. Biochem J (1985) 1.83

Effects of adrenergic and cholinergic agents upon insulin secretion in vitro. Endocrinology (1967) 1.77

Pertussis toxin inhibits chemotactic peptide-stimulated generation of inositol phosphates and lysosomal enzyme secretion in human leukemic (HL-60) cells. Proc Natl Acad Sci U S A (1985) 1.59

Receptor-induced diacylglycerol formation in permeabilized platelets; possible role for a GTP-binding protein. J Recept Res (1984) 1.51

Guanine nucleotide inhibition of cyc- S49 mouse lymphoma cell membrane adenylyl cyclase. J Biol Chem (1982) 1.42

Identification and metabolism of polyphosphoinositides in isolated islets of Langerhans. Biochem J (1983) 1.30

Muscarinic receptors and hydrolysis of inositol phospholipids in rat cerebral cortex and parotid gland. J Neurochem (1985) 1.29

Nutrient and hormone-neurotransmitter stimuli induce hydrolysis of polyphosphoinositides in rat pancreatic islets. Endocrinology (1984) 1.24

Guanine nucleotide-sensitive, high affinity binding of carbachol to muscarinic cholinergic receptors of 1321N1 astrocytoma cells is insensitive to pertussis toxin. Mol Pharmacol (1985) 1.24

Studies on the properties of triphosphoinositide phosphomonoesterase and phosphodiesterase of rabbit iris smooth muscle. Biochim Biophys Acta (1978) 1.23

Muscarinic agonist binding and phospholipid turnover in brain. J Biol Chem (1983) 1.23

Guanine nucleotides stimulate production of inositol trisphosphate in rat cortical membranes. Biochem J (1985) 1.19

Effect of acetyl choline on the secretion of glucagon and insulin from the isolated, perfused canine pancreas. Diabetes (1973) 1.17

Direct stimulation by thyrotropin-releasing hormone (TRH) of polyphosphoinositide hydrolysis in GH3 cell membranes by a guanine nucleotide-modulated mechanism. Biochem Biophys Res Commun (1985) 1.16

The Ca2+-activated polyphosphoinositide phosphodiesterase of human and rabbit neutrophil membranes. Biochem J (1984) 1.15

Agonists differentiate muscarinic receptors that inhibit cyclic AMP formation from those that stimulate phosphoinositide metabolism. J Biol Chem (1984) 1.14

A nucleotide regulatory site for somatostatin inhibition of adenylate cyclase in S49 lymphoma cells. Nature (1983) 1.13

Characterization of the cholinergic stimulation of phosphoinositide hydrolysis in rat brain slices. J Neurosci (1984) 1.12

Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites. Mol Pharmacol (1982) 1.09

Functional reconstitution of purified muscarinic receptors and inhibitory guanine nucleotide regulatory protein. Nature (1985) 1.06

The role of cyclic AMP in insulin release. Experientia (1984) 1.06

Regulation of muscarinic receptor binding by guanine nucleotides and N-ethylmaleimide. J Supramol Struct (1980) 0.97

Activation of membrane phospholipase C by vasopressin. A requirement for guanyl nucleotides. FEBS Lett (1986) 0.96

Effect of various excitatory agonists on the secretion of 5-hydroxytryptamine from permeabilised human platelets induced by Ca2+ in the presence or absence of GTP. FEBS Lett (1985) 0.93

Pertussis toxin blocks the somatostatin-induced inhibition of growth hormone release and adenosine 3',5'-monophosphate accumulation. Endocrinology (1983) 0.91

Stimulation of phosphoinositide breakdown in rat pancreatic islets by glucose and carbamylcholine. Biochem Biophys Res Commun (1983) 0.91

Muscarinic acetylcholine receptor activation causes inhibition of cyclic AMP accumulation, prolactin and growth hormone secretion in GH3 rat anterior pituitary tumour cells. Biochim Biophys Acta (1984) 0.90

Unique inhibitory profile of platelet activating factor induced calcium mobilization, polyphosphoinositide turnover and granule enzyme secretion in rabbit neutrophils towards pertussis toxin and phorbol ester. Biochem Biophys Res Commun (1985) 0.90

The role of calcium in phospholipid turnover following glucose stimulation in neonatal rat cultured islets. J Biol Chem (1984) 0.88

Dependency of acetylcholine-induced insulin release on Ca++ uptake by rat pancreatic islets. Endocrinology (1980) 0.85

Phosphodiesteratic breakdown of endogenous polyphosphoinositides in nerve ending membranes. Biochem Biophys Res Commun (1983) 0.84

Regulation of the muscarinic acetylcholine receptor: effects of phosphorylating conditions on agonist and antagonist binding. J Neurochem (1983) 0.82

Regulation of specific forms of cyclic nucleotide phosphodiesterases in cultured cells. Adv Cyclic Nucleotide Protein Phosphorylation Res (1984) 0.81

Phosphoinositide phosphorylation and hydrolysis in pancreatic islet cell membrane. Arch Biochem Biophys (1986) 0.80

Lipid associated calcium ionophores in islet cell plasma membrane following glucose stimulation. Biochem Biophys Res Commun (1984) 0.78

Glucose exerts opposite effects on muscarinic receptor binding to A and B cells of the endocrine pancreas. Endocrinology (1985) 0.78

Muscarinic receptors in pancreatic islets of the rat. Demonstration and dependence on long-term glucose environment. Biochim Biophys Acta (1983) 0.77

Articles by these authors

Down syndrome and thyroid function in adults. Lancet (1975) 2.39

Australian medical research: more resources and the right balance. Med J Aust (1998) 1.39

Problems facing the teaching hospitals. Med J Aust (1990) 1.38

The use of sodium bicarbonate in the treatment of tricyclic antidepressant-induced arrhythmias. Anaesth Intensive Care (1973) 1.31

Genetic, common environment, and individual specific components of variance for bone mineral density in 10- to 26-year-old females: a twin study. Am J Epidemiol (1998) 1.29

Pancreatic islets synthesize phospholipids de novo from glucose via acyl-dihydroxyacetone phosphate. Biochem Biophys Res Commun (1985) 1.14

The influence of genetic background on the induction of oxidative stress and impaired insulin secretion in mouse islets. Diabetologia (2006) 1.10

Glycohaemoglobin: a crucial measurement in modern diabetes management. Progress towards standardisation and improved precision of measurement. Australian Diabetes Society, the Royal College of Pathologists of Australasia and the Australasian Association of Clinical Biochemists [consensus development conference]. Med J Aust (1997) 1.10

The link between hyperglycaemia and diabetic nephropathy. Diabetologia (1992) 1.10

Hypopituitarism after extracranial irradiation: evidence for hypothalamic origin. Br Med J (1973) 1.09

Effects of nucleotides, hormones, ions, and 1,25-dihydroxycholecalciferon on 1,25-dihydroxycholecalciferol production in isolated chick renal tubules. Clin Sci Mol Med (1974) 1.08

Selective defect in insulin release in one form of spontaneous laboratory diabetes. Nat New Biol (1972) 1.07

Perspectives on casemix-based funding in Victoria. Med J Aust (1995) 1.07

Regulation of vitamin-D metabolism without parathyroid hormone. Lancet (1973) 1.07

Determinants of bone mass in 10- to 26-year-old females: a twin study. J Bone Miner Res (1995) 1.05

Feedback control of vitamin D metabolism by a nuclear action of 1,25-dihydroxycholecalciferol on the kidney. Nature (1974) 1.02

D-propranolol and DL-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine. Br Med J (1980) 1.01

The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects. Metabolism (1981) 0.99

Glucose-induced phospholipid-dependent protein phosphorylation in neonatal rat islets. Arch Biochem Biophys (1986) 0.98

Stimulation of protein kinase C and insulin release by 1-oleoyl-2-acetyl-glycerol. Eur J Biochem (1985) 0.95

Calcitonin effects on growth and on selective activation of type II isoenzyme of cyclic adenosine 3':5'-monophosphate-dependent protein kinase in T 47D human breast cancer cells. Cancer Res (1983) 0.95

Pulmonary oedema after propranolol therapy in two cases of phaeochromocytoma. Br Med J (1978) 0.94

Determinants of bone density in 30- to 65-year-old women: a co-twin study. J Bone Miner Res (2003) 0.93

High-frequency oscillation of blood free fatty acid levels in man. J Appl Physiol (1971) 0.93

Alterations in distribution of cardiac output in experimental diabetes in rats. Am J Physiol (1989) 0.92

HLA patterns and diabetic retinopathy. Br Med J (1978) 0.92

The formation of tri-iodothyronine and reverse tri-iodothyronine from thyroxine in isolated rat renal tubules. Clin Sci Mol Med Suppl (1978) 0.90

Evolution of insulin resistance in New Zealand obese mice. Diabetes (1991) 0.89

Stimulation of growth hormone release from superfused rat pituitary by extracts of hypothalamus and of human lung tumours. J Endocrinol (1973) 0.88

Effect of inhibition of aldose reductase on glucose flux, diacylglycerol formation, protein kinase C, and phospholipase A2 activation. Metabolism (1997) 0.88

The role of calcium in phospholipid turnover following glucose stimulation in neonatal rat cultured islets. J Biol Chem (1984) 0.88

An anti-actin monoclonal antibody inhibits the zona pellucida-induced acrosome reaction and hyperactivated motility of human sperm. Mol Hum Reprod (2002) 0.87

A co-twin study of the effect of calcium supplementation on bone density during adolescence. Osteoporos Int (1997) 0.87

Activity of endogenous phospholipase C and phospholipase A2 in glucose stimulated pancreatic islets. Biochem Biophys Res Commun (1984) 0.86

GTP- and inositol 1,4,5-trisphosphate-induced release of 45Ca2+ from a membrane store co-localized with pancreatic-islet-cell plasma membrane. Biochem J (1988) 0.86

Inhibition by propranolol of 3,5,3'-triiodothyronine formation from thyroxine in isolated rat renal tubules: an effect independent of beta-adrenergic blockade. Endocrinology (1980) 0.86

Regulation of 25-hydroxy-vitamin D-1 alpha-hydroxylase in chick isolated renal tubules: effects of prostaglandin E2, frusemide and acetylsalicylic acid. Clin Sci (Lond) (1981) 0.85

Increased vasodilatory prostaglandin production in the diabetic rat retinal vasculature. Curr Eye Res (1999) 0.85

Role of transglutaminase in insulin release. Study with glycine and sarcosine methylesters. Endocrinology (1985) 0.84

The effects of digestive enzymes on characteristics of placental insulin receptor. Comparison of particulate and soluble receptor preparations. Biochem J (1978) 0.84

Production of 6-oxo-prostaglandin F1alpha by rat aorta: influence of diabetes, insulin treatment, and caloric deprivation. Diabetes (1981) 0.84

An important role of actin polymerization in the human zona pellucida-induced acrosome reaction. Mol Hum Reprod (1999) 0.84

Increased hyaluronan production in the glomeruli from diabetic rats: a link between glucose-induced prostaglandin production and reduced sulphated proteoglycan. Diabetologia (1995) 0.83

Phospholipase C mimics insulin action on pyruvate dehydrogenase and insulin mediator generation but not glucose transport or utilization. Cell Signal (1990) 0.83

Isolation of insulin-sensitive phosphatidylinositol-glycan from rat adipocytes. Its impaired breakdown in the streptozotocin-diabetic rat. Biochem J (1990) 0.83

Fasting plasma glucose in children. Aust Paediatr J (1980) 0.83

Effects of phosphatidic acid on islet cell phosphoinositide hydrolysis, Ca2+, and adenylate cyclase. Diabetes (1989) 0.82

Defective insulin secretory response to glucose in the New Zealand obese mouse. Improvement with restricted diet. Diabetes (1973) 0.82

Impaired glucose tolerance, hyperinsulinemia, and hypertriglyceridemia in Australian aborigines from the desert. Diabetes Care (1988) 0.82

Presence of membrane-associated phosphatidate phosphohydrolase activity in cultured islets and its stimulation by glucose. FEBS Lett (1985) 0.82

The effects of trypsin and phospholipase C on insulin binding and action in the isolated adipocyte. Biochem J (1980) 0.81

Insulin-dependent contractility of glomerular mesangial cells in response to angiotensin II, platelet-activating factor and endothelin is attenuated by prostaglandin E2. Biochem J (1990) 0.81

Phosphoinositide phosphorylation and hydrolysis in pancreatic islet cell membrane. Arch Biochem Biophys (1986) 0.80

Glucose utilization in relation to insulin secretion in NZO and C57Bl mouse islets. Endocrinology (1980) 0.80

Effect of islet activating protein on glucose tolerance, insulin secretion and insulin responsiveness in the NZO mouse. Diabetologia (1984) 0.80

Production of hyaluronan by glomerular mesangial cells in response to fibronectin and platelet-derived growth factor. Kidney Int (1996) 0.80

The in vitro effect of 1 alpha,25-dihydroxyvitamin D3 on insulin production by neonatal rat islets. Biochem Biophys Res Commun (1989) 0.80

Production of 6-oxo-prostaglandin F1 alpha and prostaglandin E2 by isolated glomeruli from normal and diabetic rats. Br Med J (Clin Res Ed) (1982) 0.80

The effect of long-term diphenylhydantoin therapy on glucose tolerance and insulin secretion: a controlled trial. Clin Endocrinol (Oxf) (1980) 0.79

Impaired insulin action in adipocytes of New Zealand obese mice: a role for postbinding defects in pyruvate dehydrogenase and insulin mediator activity. Metabolism (1988) 0.79

Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis. Osteoporos Int (1997) 0.79

Effect of prostaglandin E2 and hyaluronan on mesangial cell proliferation. A potential contribution to glomerular hypercellularity in diabetes. Diabetes (1996) 0.79

Chronic diphenylhydantoin therapy does not reduce plasma 25-hydroxy-vitamin D. Clin Endocrinol (Oxf) (1979) 0.78

Thyroid hormone levels and protein binding in patients on long-term diphenylhydantoin treatment. Clin Endocrinol (Oxf) (1977) 0.78

Adenylate cyclase responsiveness of human insulinomas. Horm Metab Res (1981) 0.78

Failure of IGF-1 to affect protein turnover in muscle from growth-retarded neonatal rats. J Dev Physiol (1990) 0.78

Country profile: Australia. Lancet (1998) 0.78

Albuminuria in aborigines and Europids of south-eastern Australia. Med J Aust (1993) 0.78

Lipid associated calcium ionophores in islet cell plasma membrane following glucose stimulation. Biochem Biophys Res Commun (1984) 0.78

Norman MacAlister Gregg Lecture. The pathogenesis of diabetic retinopathy. Aust N Z J Ophthalmol (1996) 0.78

The effect of prostacyclin and 6-keto-prostaglandin F1 alpha on insulin secretion and cyclic adenosine 3', 5'-monophosphate content in isolated rat islets. Diabetes (1981) 0.77

Endogenous ionophoretic activity in the neonatal rat pancreatic islet. FEBS Lett (1982) 0.77

Methylxanthine effects on cyclic adenosine 3':5' monophosphate phosphodiesterase activity in preparations of neonatal rat cerebellum: modification by trifluoperazine. Biochem Biophys Res Commun (1981) 0.77

Enhanced glucose-induced insulin release and endogenous Ca2+ ionophoretic activity in neonatal rat islets following islet-activating protein. Biochem Biophys Res Commun (1983) 0.77

Biphasic action of prostaglandin E2 on conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 in chick renal tubules. Prostaglandins (1984) 0.77

Hyperinsulinaemia and obesity in aborigines of south-eastern Australia, with comparisons from rural and urban Europid populations. Diabetes Res Clin Pract (1993) 0.77

Opposing actions of methylxanthines and dibutyryl cyclic AMP on 1,25 dihydroxyvitamin D3 production and calcium fluxes in isolated chick renal tubules. Biochem Biophys Res Commun (1984) 0.77

Vitamin D. Clin Endocrinol (Oxf) (1977) 0.77

Glucocorticoids decrease in conversion of thyroxine into 3, 5, 3'-tri-iodothyronine by isolated rat renal tubules. Clin Sci (Lond) (1982) 0.77

A role for calmodulin in renal production of 1,25-dihydroxyvitamin D3. Endocrinology (1986) 0.77

Altered microvascular reactivity in streptozotocin-induced diabetes in rats. Am J Physiol (1989) 0.77

Diminished production of thromboxane B2 and prostaglandin E by stimulated polymorphonuclear leukocytes from insulin-treated diabetic subjects. Diabetes (1983) 0.76

Blood pressure, lipids and other risk factors for cardiovascular disease in Aborigines and persons of European descent of southeastern Australia. Aust J Public Health (1994) 0.76

The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus. Diabetologia (1991) 0.76

Lack of effect of gliclazide on early diabetic nephropathy and retinopathy: a two-year controlled study. Diabetes Res Clin Pract (1987) 0.76

Increased phosphorylation of focal adhesion kinase in diabetic rat kidney glomeruli. Diabetologia (1995) 0.76

Biochemical changes during surface cooling for deep hypothermia in open-heart surgery. J Thorac Cardiovasc Surg (1973) 0.76

Stimulation by human chorionic gonadotropin of prostaglandin synthesis by early human placental tissue. J Clin Endocrinol Metab (1991) 0.76

Lipoprotein-induced prostacyclin production in endothelial cells and effects of lipoprotein modification. Am J Physiol (1996) 0.75

Guidelines for no-CPR orders. Med J Aust (1995) 0.75